Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


20.11.2017

1 Ann Surg
1 Ann Surg Oncol
1 BMC Cancer
1 Br J Dermatol
1 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
2 J Am Acad Dermatol
1 J Surg Oncol
2 Melanoma Res
1 Ophthalmology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. FERRARA G, Improta G
    Sentinel Node Biopsy in Melanoma: Lessons Learned From Different Positivity Rates From Different Hospitals.
    Ann Surg. 2017;266:e81.
    PubMed     Text format    


    Ann Surg Oncol

  2. CHAI C, Szabunio M, Cook C, Zager J, et al
    Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply.
    Ann Surg Oncol. 2017 Nov 13. doi: 10.1245/s10434-017-6231.
    PubMed     Text format    


    BMC Cancer

  3. CIRILO PDR, de Sousa Andrade LN, Correa BRS, Qiao M, et al
    MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1.
    BMC Cancer. 2017;17:750.
    PubMed     Text format     Abstract available


    Br J Dermatol

  4. WINSLOW UC, Nordestgaard BG, Afzal S
    High plasma 25-hydroxyvitamin D and high risk of non-melanoma skin cancer: a Mendelian randomisation study of 97849 individuals.
    Br J Dermatol. 2017 Nov 16. doi: 10.1111/bjd.16127.
    PubMed     Text format     Abstract available


    Cancer Res

  5. MO X, Zhang H, Preston S, Martin K, et al
    Interferon-2; signaling in melanocytes and melanoma cells regulates expression of CTLA-4.
    Cancer Res. 2017 Nov 17. pii: canres.1615.2017.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  6. GIDE TN, Wilmott JS, Scolyer RA, Long GV, et al
    Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma.
    Clin Cancer Res. 2017 Nov 10. pii: clincanres.2267.2017.
    PubMed     Text format     Abstract available


    Int J Cancer

  7. KAWADA T
    Prognosis of sentinel lymph node biopsy in patients with thick melanoma by a propensity score matching prospective study.
    Int J Cancer. 2017 Nov 18. doi: 10.1002/ijc.31163.
    PubMed     Text format    


    J Am Acad Dermatol

  8. VERZI AE, Quan VL, Walton K, Martini MC, et al
    The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: a retrospective, case-control study.
    J Am Acad Dermatol. 2017 Nov 11. pii: S0190-9622(17)32686.
    PubMed     Text format     Abstract available

  9. KOOISTRA L, Chiang K, Dawes S, Gittleman H, et al
    Racial disparities and insurance status: an epidemiologic analysis of Ohio melanoma patients.
    J Am Acad Dermatol. 2017 Nov 11. pii: S0190-9622(17)32684.
    PubMed     Text format    


    J Surg Oncol

  10. DURHAM AB, Schwartz JL, Lowe L, Zhao L, et al
    In reply: Management of thin melanoma.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24858.
    PubMed     Text format    


    Melanoma Res

  11. HADDEN NJ, McIntosh JRD, Jay S, Whittaker PJ, et al
    Prognostic factors in patients with metastatic spinal cord compression secondary to melanoma: a systematic review.
    Melanoma Res. 2017 Nov 14. doi: 10.1097/CMR.0000000000000411.
    PubMed     Text format     Abstract available

  12. KUO JC, Lilly LB, Hogg D
    Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review.
    Melanoma Res. 2017 Nov 14. doi: 10.1097/CMR.0000000000000410.
    PubMed     Text format     Abstract available


    Ophthalmology

  13. THARIAT J, Rahmi A, Salleron J, Mosci C, et al
    Proton Beam Therapy for Iris Melanomas in 107 Patients.
    Ophthalmology. 2017 Nov 8. pii: S0161-6420(17)32582.
    PubMed     Text format     Abstract available


    PLoS One

  14. PEREZ EC, Xander P, Laurindo MFL, Novaes E Brito RR, et al
    The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes.
    PLoS One. 2017;12:e0187333.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: